EUROFINS LABORATOIRE DERMSCAN : revenue, balance sheet and financial ratios

EUROFINS LABORATOIRE DERMSCAN is a French company founded 36 years ago, specialized in the sector Ingénierie, études techniques. Based in VILLEURBANNE (69100), this company of category GE shows in 2024 a revenue of 19.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - EUROFINS LABORATOIRE DERMSCAN (SIREN 353215890)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 19 395 070 € 18 715 636 € 18 335 616 € 17 543 957 € 12 950 229 € 13 045 103 € 11 881 748 € 10 601 088 € N/C
Net income 1 106 046 € 341 199 € 2 119 463 € 1 093 781 € -193 289 € 380 499 € 569 669 € 332 458 € 306 203 €
EBITDA 193 850 € -44 438 € 587 014 € 704 470 € -864 804 € 123 495 € 460 153 € 101 541 € N/C
Net margin 5.7% 1.8% 11.6% 6.2% -1.5% 2.9% 4.8% 3.1% N/C

Revenue and income statement

In 2024, EUROFINS LABORATOIRE DERMSCAN achieves revenue of 19.4 M€. Over the period 2017-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +9.0%. Vs 2023: +4%. After deducting consumption (53 k€), gross margin stands at 19.3 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 194 k€, representing 1.0% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.1 M€, i.e. 5.7% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

19 395 070 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

19 341 822 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

193 850 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

358 326 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

1 106 046 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

1.0%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 24%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 1.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1.813%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

23.583%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

1.341%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.133

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

22.9%

Solvency indicators evolution
EUROFINS LABORATOIRE DERMSCAN

Sector positioning

Debt ratio
1.81 2024
2022
2023
2024
Q1: 0.0
Med: 8.24
Q3: 42.82
Good

In 2024, the debt ratio of EUROFINS LABORATOIRE DERM... (1.81) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
23.58% 2024
2022
2023
2024
Q1: 11.26%
Med: 37.88%
Q3: 61.35%
Average -10 pts over 3 years

In 2024, the financial autonomy of EUROFINS LABORATOIRE DERM... (23.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.13 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.9 years
Average

In 2024, the repayment capacity of EUROFINS LABORATOIRE DERM... (0.13) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 211.51. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 15.9x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

211.509

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

15.924

Liquidity indicators evolution
EUROFINS LABORATOIRE DERMSCAN

Sector positioning

Liquidity ratio
211.51 2024
2022
2023
2024
Q1: 148.99
Med: 229.96
Q3: 405.09
Average -7 pts over 3 years

In 2024, the liquidity ratio of EUROFINS LABORATOIRE DERM... (211.51) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
15.92x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 2.04x
Excellent

In 2024, the interest coverage of EUROFINS LABORATOIRE DERM... (15.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 60 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 31 days. The company must finance 29 days of gap between collections and payments. Overall, WCR represents 60 days of revenue, i.e. 3.2 M€ to permanently finance.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

3 241 498 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

60 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

31 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

60 j

WCR and payment terms evolution
EUROFINS LABORATOIRE DERMSCAN

Positioning of EUROFINS LABORATOIRE DERMSCAN in its sector

Comparison with sector Ingénierie, études techniques

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (40 transactions). This range of 908 839€ to 2 319 773€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
908k€ 1268k€ 2319k€
1 268 877 € Range: 908 839€ - 2 319 773€
NAF 5 année 2024

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 40 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Ingénierie, études techniques)

Compare EUROFINS LABORATOIRE DERMSCAN with other companies in the same sector:

Voir toutes les statistiques du secteur Ingénierie, études techniques

Frequently asked questions about EUROFINS LABORATOIRE DERMSCAN

What is the revenue of EUROFINS LABORATOIRE DERMSCAN ?

The revenue of EUROFINS LABORATOIRE DERMSCAN in 2024 is 19.4 M€.

Is EUROFINS LABORATOIRE DERMSCAN profitable?

Yes, EUROFINS LABORATOIRE DERMSCAN generated a net profit of 1.1 M€ in 2024.

Where is the headquarters of EUROFINS LABORATOIRE DERMSCAN ?

The headquarters of EUROFINS LABORATOIRE DERMSCAN is located in VILLEURBANNE (69100), in the department Rhone.

Where to find the tax return of EUROFINS LABORATOIRE DERMSCAN ?

The tax return of EUROFINS LABORATOIRE DERMSCAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EUROFINS LABORATOIRE DERMSCAN operate?

EUROFINS LABORATOIRE DERMSCAN operates in the sector Ingénierie, études techniques (NAF code 71.12B). See the 'Sector positioning' section above to compare the company with its competitors.